SYNTA PHARMACEUTICALS CORP - COM (SNTA)

Q3 2014 13F Holders as of 30 Sep 2014

Type / Class
Equity / COM
Total 13F shares
55,472,361
Share change
+3,344,693
Total reported value
$166,981,752
Put/Call ratio
208%
Price per share
$3.01
Number of holders
92
Value change
+$9,790,145
Number of buys
54
Number of sells
22

Institutional Holders of SYNTA PHARMACEUTICALS CORP - COM (SNTA) as of Q3 2014

As of 30 Sep 2014, SYNTA PHARMACEUTICALS CORP - COM (SNTA) was held by 92 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 55,472,361 shares. The largest 10 holders included CAXTON CORP, FMR LLC, JENNISON ASSOCIATES LLC, BlackRock Fund Advisors, VANGUARD GROUP INC, Jefferies Group LLC, GOLDMAN SACHS GROUP INC, State Street Corp, NORTHERN TRUST CORP, and BlackRock Institutional Trust Company, N.A.. This page lists 92 institutional shareholders reporting positions in this security for the Q3 2014 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.